Classified in: Health, Covid-19 virus
Subjects: MAV, CFG

Media Advisory - Deputy Prime Minister's itinerary for Monday, March 30, 2020

OTTAWA, March 30, 2020 /CNW/ -

Note: All times local

Ottawa, Ontario

The Deputy Prime Minister will chair the Cabinet Committee on the federal response to the coronavirus disease (COVID-19).

Closed to media.

12:00 p.m.	The Deputy Prime Minister will join ministers and Government of Canada officials to provide an update on COVID-19.

	Room 225
	West Block
	Parliament Hill

	Notes for media:

	Media are asked to arrive no later than 11:45 a.m. The media availability will also be held by teleconference. Toll-free (Canada/US) dial-in number: 1-866-206-0153 Passcode: 1622050#

SOURCE Deputy Prime Minister's Office

These press releases may also interest you

at 06:37	/C O R R E C T I O N -- OSR Holdings/
	In the news release, OSR Holdings and SillaJen have entered into a Memorandum of Understanding to collaboratively pursue the development of innovative therapeutics and enter the U.S. market, issued 22-Apr-2024 by OSR Holdings over PR Newswire, we are...
at 06:21	Zayed Sustainability Prize's Beyond2020 Initiative Deploys Life-saving Digital Mammograms in Costa Rica
	Beyond2020, the flagship initiative launched by the Zayed Sustainability Prize, the UAE's pioneering award for sustainability and humanitarianism, today announced the deployment of AI-powered mammography services across Costa Rica to support the...
at 06:18	Surrey FA and Chelsea FC Foundation Empower Female Refugees and Unite Through Football
	Surrey FA and Chelsea FC Foundation are proud to announce their collaborative effort once again to offer empowering coaching sessions to female refugees in the local community. These sessions will provide an opportunity for women to engage with...
at 06:05	BeiGene Receives European Commission Approval for Tislelizumab as Treatment for Non-Small Cell Lung Cancer
	BeiGene, Ltd. , a global oncology company, today announced that the European Commission (EC) has approved tislelizumab as a treatment for non-small cell lung cancer (NSCLC) across three indications, including first- and second-line use....
at 06:05	Vizient conducts first Insight: Cell, Gene, and Specialty Pharmacy Symposium
	Vizient, Inc. hosted its inaugural Insight: Cell, Gene, and Specialty Pharmacy Symposium, bringing together leading healthcare providers, payers and manufacturers of high-cost, ultra-specialty pharmaceuticals along with other stakeholders to discuss...
at 06:05	SprintRay Introduces Revolutionary MIDAS
	SprintRay, the leader in dental 3D printing, unveiled the Company's most significant innovation to-date to over 250 dental professionals at 3DNext, their summit in Miami. The Midas Digital Press 3D Printer is poised to not only transform dental...
	More news about Health...

News published on 30 march 2020 at 07:31 and distributed by: